gms | German Medical Science

72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

06.06. - 09.06.2021

ePoster Montag, 07.06.2021
Neuroonkologie III/Neurooncology III

Meeting Abstract (P053)

A multi-omics approach to identify markers for glioblastoma recurrency

Schäfer A, Benescu AC, Evers L, Meier L, Nimsky C, Bartsch JW
Meeting Abstract (P054)

Analysis of influence of cortex temperature on patient cognition during awake-surgery – a pilot study

Knipps J, Kamp MA, Rapp M, Hänggi D, Sabel M
Meeting Abstract (P055)

AT101 – a specific therapy against glioma stem-like cells – mechanism of action in the microenvironment of the tumour

Hellmold D, Caylioglu D, Meyer R, Kubelt C, Synowitz M, Held-Feindt J
Meeting Abstract (P056)

Breaching the blood-brain Barrier (BBB) via Tumour Treating Fields (TTFields)

Salvador E, Keßler AF, Burek M, Brami CT, Voloshin-Sela T, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C
Meeting Abstract (P057)

Carbonic Anhydrase XII blocking Antibody 6A10 can reduce ZEB1 and motility of glioblastoma stem cells

Chen TW, Nickel AC, Muhammad S, Hänggi D, Zeidler R, Kahlert UD, Martinez MV
Meeting Abstract (P058)

Characterisation of carbonic anhydrase 2 (CA-2) as a factor conferring temozolomide resistance in GBM stem cells

Zhao K, Culmsee C, Nimsky C, Bartsch JW
Meeting Abstract (P059)

Characterisation of heterogeneous antigen-expression pattern comparing glioblastoma cell lines, patient-derived cells and patients’ glioblastoma tissue

Dufner V, Schulz E, Monoranu C, Hudecek M, Hagemann C, Ernestus RI, Löhr M, Nerreter T
Meeting Abstract (P060)

CNS invasion in meningioma – detection by the surgeon and pathologist and its prognostic value

Behling F, Fodi C, Gepfner-Tuma I, Machetanz K, Renovanz M, Skardelly M, Bornemann A, Honegger J, Tabatabai G, Tatagiba M, Schittenhelm J
Meeting Abstract (P061)

Personalised treatment option in translational neuro-oncology – JAK/STAT-inhibition reverses myeloid cell-induced anti-tumour-immunity in T cells

Heiland DH, Ravi VM, Neidert N, Hofmann U, Beck J, Schnell O
Meeting Abstract (P062)

Quantification of PpIX-fluorescence of cerebral breast cancer metastases

Knipps J, Rapp M, Hänggi D, Sabel M, Kamp MA
Meeting Abstract (P063)

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce

Vargas-Toscano A, Nickel AC, Li G, Kamp MA, Muhammad S, Leprivier G, Fritsche E, Barker RA, Sabel M, Steiger HJ, Zhang W, Hänggi D, Kahlert UD
Meeting Abstract (P064)

Reshaping the GBM landscape to enable targeting of chemo-resistant tumours

Joseph K, Maier J, Ravi VM, Beck J, Hofmann U, Schnell O, Heiland DH
Meeting Abstract (P065)

Evaluating the need for a regional virtual neurooncological tumour board – a survey study

Sommer B, Hackanson B, Konietzko I, Kahl KH, Stüben G, Berlis A, Maurer C, Märkl B, Schmid C, Trepel M, Shiban E